ISCHEMIA-CKD EXTEND: After 8 Years, Routine Invasive Care Did Not Improve Survival in Advanced CKD With Stable Coronary Disease

Eight-year follow-up of the ISCHEMIA-CKD trial, presented at AHA Scientific Sessions 2026 and published in Circulation, found no difference in all-cause or cardiovascular mortality between an initial invasive strategy and initial medical therapy in 777 people with advanced CKD and at least moderate

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.